Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Andrews

Showing results (851-860 of 875) with videos related to

Pageof 88
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of successJeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 26, 2014
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristicsHiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, et al.
Journal of Substance Abuse Treatment|February 7, 2022
Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level interventionMari-Lynn Drainoni, Hannah K Knudsen, Kathy Adams, et al.
Journal of Medical Genetics|February 2, 2018
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes <i>SDHB</i>, <i>SDHC</i> and <i>SDHD</i>Katrina A Andrews, David B Ascher, Douglas Eduardo Valente Pires, et al.
Pain|December 20, 2015
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerationsNick A Andrews, Alban Latrémolière, Allan I Basbaum, et al.
Accountability in Research|March 25, 2026
International multi-stakeholder consensus statement on patient, carer and public involvement to enhance clinical trial integrityKhalid Saeed Khan, Mohamed Fawzy, Balázs Juhász, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identificationKarl Semaan, Marc Eid, Damien Vasseur, et al.
The Journal of Clinical Investigation|February 21, 2018
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapyLara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Behavior Genetics|September 23, 2015
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsTae-Hwi Schwantes-An, Juan Zhang, Li-Shiun Chen, et al.
Pageof 88

Showing results (851-860 of 875) with videos related to

Sort By:
Pageof 88
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 31, 2023
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of successJeremy M Shefner, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 26, 2014
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristicsHiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, et al.
Journal of Substance Abuse Treatment|February 7, 2022
Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level interventionMari-Lynn Drainoni, Hannah K Knudsen, Kathy Adams, et al.
Journal of Medical Genetics|February 2, 2018
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes <i>SDHB</i>, <i>SDHC</i> and <i>SDHD</i>Katrina A Andrews, David B Ascher, Douglas Eduardo Valente Pires, et al.
Pain|December 20, 2015
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerationsNick A Andrews, Alban Latrémolière, Allan I Basbaum, et al.
Accountability in Research|March 25, 2026
International multi-stakeholder consensus statement on patient, carer and public involvement to enhance clinical trial integrityKhalid Saeed Khan, Mohamed Fawzy, Balázs Juhász, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2026
Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identificationKarl Semaan, Marc Eid, Damien Vasseur, et al.
The Journal of Clinical Investigation|February 21, 2018
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapyLara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Behavior Genetics|September 23, 2015
Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsTae-Hwi Schwantes-An, Juan Zhang, Li-Shiun Chen, et al.
Pageof 88